$425.1M in CY2024 Part D spend253K claims · 50K beneficiaries · 329 plans surveyed
Questions a plan sponsor actually asks.
What is Lumateperone used for?
Lumateperone treats schizophrenia, bipolar disorder, and related conditions by modulating dopamine and serotonin receptors.
Is there a generic for Lumateperone?
No. Lumateperone is brand-only with no generic equivalents currently in market.
How much does my plan pay for Lumateperone?
Across 329 Part D plans, Lumateperone averages $57.36/unit (NADAC). Lowest available: $57.33/unit. Highest in distribution: $57.40/unit.
Is Lumateperone on the FDA shortage list?
No. Lumateperone is not currently on the FDA Drug Shortage Database.
7 additional drug-specific questions are indexed in the page's FAQPage schema for search engines and LLM crawlers, beyond what renders visually above. View page source for the complete JSON-LD.
Same class. Different math.
Sources · every number above traces back.
Drug identity, dosage forms, brand names: openFDA NDC Directory · First approval, ANDA history: FDA Orange Book (3 approvals on file) · NADAC unit costs: CMS NADAC weekly file (3 NDCs benchmarked) · Formulary tier and PA placement: CMS Part D Formulary file (329 plans) · Annualized spend, claims, beneficiaries: CMS Part D Spending Dashboard (CY2024) · Shortage status: FDA Drug Shortage Database · 340B exposure: HRSA OPAIS. Methodology and reproducibility notes on /methodology.